Search
Search
Little Eyes - Big Topics: An AAPOS Podcast
05.20.24
Gregory Ostrow, MD, joins Jennifer Galvin, MD, to discuss his entrepreneurism in pediatric ophthalmology and the starting of Sydnexis, a clinical-stage biopharmaceutical company he founded. He describes the journey to discovering a way to neutralize and stabilize compounded atropine eye drops to effectively treat myopia in pediatric patients. He also shares information from the STAR study, a phase 3 clinical trial evaluating the company’s patented formulation of low-dose atropine for myopia control.
View full description +
Subscribe
12.20.24
Why choose Pediatric Ophthalmology? Medical Student, Resident, & Attending PerspectivesJennifer Galvin, MD; Alexander Valentine, MD; Angela Ngo; and Courtney Kraus, MD
11.26.24
Ophthalmology for All: Building More Inclusive SpacesJennifer Galvin, MD; Nadia Abbas; Dolly Ann Padovani-Claudio, MD, PhD; Ore-Ofe Adesina, MD
10.25.24
Advocacy in Pediatric OphthalmologyJennifer Galvin, MD; Alex Valentine, MD; Michelle Falcone, MD; and Michael Puente, MD
10.03.24
Current Approaches and Future Directions in Retinopathy of Prematurity ManagementJennifer Galvin, MD; Christine Law, MD; Gil Binenbaum, MD, MSCE; Emily McCourt, MD; and Jennifer Jung, MD
08.12.24
Identification and Treatment of Pediatric KeratoconusSruti Rachapudi, MD, MBA; and Simon Fung, MD, MA(Oxon), FRCOphth
07.12.24
The Pediatric Eye Disease Investigator GroupJennifer Galvin, MD; Stacy Pineles, MD; and Katherine Weise, OD, MBA, FAAO
05.20.24
Sydnexis: Pearls from a pediatric ophthalmologist entrepreneur a decade inGregory Ostrow, MD; and Jennifer Galvin, MD
Show More
